Noble Financial Downgrades Pharmasset (VRUS) to Sell
Tweet
Share
E-mailGet Alerts VRUS Hot Sheet
Price: $0.00 --0%
Rating Summary:
3 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 3 | New: 6
Rating Summary:
3 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 3 | New: 6
Join SI Premium – FREE
Noble Financial downgraded Pharmasset (NASDAQ: VRUS) from Buy to Sell, price target raised from $95 to $135.
For an analyst ratings summary and ratings history on Pharmasset click here. For more ratings news on Pharmasset click here.
Shares of Pharmasset closed at $134.14 yesterday.
For an analyst ratings summary and ratings history on Pharmasset click here. For more ratings news on Pharmasset click here.
Shares of Pharmasset closed at $134.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades Z AI Co Ltd (2513:HK) to Buy
- Morgan Stanley Downgrades AutoNation Inc. (AN) to Equalweight
- Jefferies Downgrades Skanska AB (SKAB:SS) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Noble FinancialSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
